Where does Revolutionary Medical Devices, Inc. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Revolutionary Medical Devices, Inc. ranks #20,326 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Revolutionary Medical Devices, Inc. hold?

Revolutionary Medical Devices, Inc. holds 14 US utility patents granted between 2017 and 2023, spanning 4 technology areas.

What is Revolutionary Medical Devices, Inc.'s Innovation Score?

Revolutionary Medical Devices, Inc. has an Innovation Score of 23.9 out of 100 (13th percentile of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

Is Revolutionary Medical Devices, Inc.'s patent grant rate increasing or decreasing?

Revolutionary Medical Devices, Inc.'s recent grant velocity is +80% compared to the prior five-year period (grant years, not application filing dates). This indicates accelerating grant output.

What does claim depth mean for Revolutionary Medical Devices, Inc.'s patents?

Revolutionary Medical Devices, Inc.'s patents average 6.9 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Revolutionary Medical Devices, Inc. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

Revolutionary Medical Devices, Inc.

Q: What technology areas does Revolutionary Medical Devices, Inc. focus on?

Revolutionary Medical Devices, Inc.'s top technology area is A61M (Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor) with 6 patents, ranking #1,115 of 3,490 assignees active in that subclass. Grants appear in 4 CPC subclasses total.

USPTO PatentsView assignee record - 14 granted patents across 4 technology areas, recorded in grant years 2017–2023. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61M (Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Revolutionary ranks #20,326 of 49,997 tracked US assignees by granted-patent volume, with 14 patents across 4 technology areas.

#20,326
of 49,997 US assignees by volume: 13th percentile
by Innovation Score (23.9/100): 6.9
avg claims per patent: +80%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R20326 · US Corporation #20,326 · 14 grants

GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-SPARSE · TYPE-USCORP · VEL-SURGE · BOOK-FULL

GRANTS-MICRO 14 grants
MID-PACK #20,326/49,997
PHOTO-FINISH ReveraGen BioPharma
CPC-NARROW A61M · 4 areas
INNOV-THIN 23.9/100
CLAIMS-SPARSE 6.9 claims/avg
TYPE-USCORP US Corporation
VEL-SURGE +80% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: ReveraGen BioPharma, Inc. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Revolutionary’s 23.9 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 9.4 pts (39%) Velocity 3.3 pts (14%) Breadth 7.1 pts (30%) Claim depth 4.2 pts (18%)

Qualcomm Incorporated · highest

85
Revolutionary… · this assignee

24
3D Lighting… · lowest

7

What this shows Revolutionary's Innovation Score is 23.9/100 (13th percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Revolutionary?

Each dot is one of Revolutionary’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Revolutionary’s own 6.9 claims/patent is at or below the 14.4 median for these volume peers. Volume here does not track with deeper claims; several lower-volume peers claim more thoroughly per patent.

Revolutionary vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Revolutionary's grants concentrate

Revolutionary Medical Devices, Inc. is a focused PatentsView assignee: 4 CPC subclasses with 42.9% of grants classified under A61M (Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor). Peak complete grant year is 2019 (3 grants) versus a trough of 1 in 2017. By volume, Revolutionary sits between ReveraGen BioPharma, Inc. and Rosti Mepal Support B.V..

Revolutionary's three-year grant acceleration

Revolutionary Medical Devices, Inc. shows 4 grants in 2022–2024 against only 8 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Reveragen Biophar…

14
Revision Military

14
Revo Brand Group

14
Revolutionice

14
Ricardo UK

14
Rightline Equipme…

14
Rosendin Electric

14
Rosti Mepal Suppo…

14
Revolutionary Med… ◀

14

What this shows Revolutionary holds 14 patents at rank #20,339, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Revolutionary

By rank, the assignees closest to #20,339 in granted patent volume.

Leaders in A61M (Devices FOR Introducing Media Into)

Other assignees with the most granted patents in Revolutionary's primary technology class.

Revolutionary's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

24 13th percentile higher than 13% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2017–2023

Grants by year

Teal-shaded recent years (2020–present) versus the 2017–2019 baseline. Full figures in the table below.

View data table

Revolutionary Medical Devices, Inc. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2017	1	7.1%
2018	1	7.1%
2019	3	21.4%
2020	3	21.4%
2021	2	14.3%
2022	3	21.4%
2023	1	7.1%

Which technologies does Revolutionary Medical Devices, Inc. patent most?

A61M - Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor 6

A61B - DIAGNOSIS; SURGERY; Identification 5

A61G - Transport, Personal Conveyances, OR Accommodation Specially Adapted FOR Patients OR Disabled Persons ; Operating Tables OR CHAIRS; Chairs FOR DENTISTRY; Funeral Devices 1

A62B - Devices, Apparatus OR Methods FOR Life-saving 1

Top 4 of 4 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Revolutionary Medical Devices, Inc.'s patent record in context - here's where to go next.

Revolutionary Medical Devices, Inc.'s lead technology class is A61M (Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor), 42.9% of its portfolio - see every assignee active in that class. Explore A61M
Ranked #20,326 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Revolutionary Medical Devices, Inc. against ReveraGen BioPharma, Inc., an assignee filing at a similar volume. Compare portfolios
Innovation Score of 23.9/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.